Altria Group, Inc. logo

Altria Group, Inc. (MO)

Market Closed
25 Feb, 20:00
NYSE NYSE
$
69. 70
+0.45
+0.65%
$
113.43B Market Cap
8.52 P/E Ratio
4.24% Div Yield
6,509,741 Volume
4.95 Eps
$ 69.25
Previous Close
Day Range
68.34 69.98
Year Range
52.82 69.98
Want to track MO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
MO earnings report is expected in 60 days (27 Apr 2026)
Investors Heavily Search Altria Group, Inc. (MO): Here is What You Need to Know

Investors Heavily Search Altria Group, Inc. (MO): Here is What You Need to Know

Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 1 year ago
Altria Group: Market Share Woes Continue To Undermine This Value Prospect

Altria Group: Market Share Woes Continue To Undermine This Value Prospect

I maintain a 'hold' rating for Altria Group due to its declining market share and the ongoing reduction in smoking rates. Despite attractive valuation and growth in segments like NJOY and on!, overall market share and cigarette volume continue to decline. Revenue growth is driven by higher pricing, but this isn't enough to offset the weaknesses in the company's core markets.

Seekingalpha | 1 year ago
3 Reasons to Buy Altria Stock Like There's No Tomorrow

3 Reasons to Buy Altria Stock Like There's No Tomorrow

3 Reasons to Buy Altria Stock Like There's No Tomorrow

Fool | 1 year ago
3 High-Yields Unfazed by the Election: Altria, Truist, Verizon

3 High-Yields Unfazed by the Election: Altria, Truist, Verizon

The recent surge across the markets, led by sectors like tech, energy, financials, and industrials, demonstrates that volatility surrounding election results can often drive attention away from more conservative, income-focused investments.

Marketbeat | 1 year ago
The Zacks Analyst Blog Philip Morris, Altria and British American Tobacco

The Zacks Analyst Blog Philip Morris, Altria and British American Tobacco

Philip Morris, Altria and British American Tobacco are included in this Analyst Blog.

Zacks | 1 year ago
Altria: Sit Back And Continue To NJOY The Dividends

Altria: Sit Back And Continue To NJOY The Dividends

During Q3 earnings, Altria showed strong price appreciation thanks to continued growth in NJOY and on!. Smokeable products continued to see lower volumes due to consumers becoming more health conscious, which will continue to be a risk for the company going forward. Altria was able to offset this with accelerated buybacks, significantly higher than the previous year's quarter.

Seekingalpha | 1 year ago
Altria's Shares Rallied, but Is the Stock a Buy?

Altria's Shares Rallied, but Is the Stock a Buy?

Altria's stock is up by more than 30% over the past year, with a recent, and sizable, post-earnings jump. Is it worth this price?

Fool | 1 year ago
These Stock Gems Yielding 4.5% Or More Look Even Better Now

These Stock Gems Yielding 4.5% Or More Look Even Better Now

The Fed cut short-term rates again — making decent yields even more attractive. But there are some dividend gems to be found in the S&P 500.

Investors | 1 year ago
Is Altria Group a Buy, Sell, or Hold in 2025?

Is Altria Group a Buy, Sell, or Hold in 2025?

It's time to reassess the stock after Altria's surge this year.

Fool | 1 year ago
Is Altria Stock Going to $60? 1 Wall Street Analyst Thinks So.

Is Altria Stock Going to $60? 1 Wall Street Analyst Thinks So.

The company was the subject of a bullish research update on the back of a convincing quarterly earnings beat.

Fool | 1 year ago
Here is What to Know Beyond Why Altria Group, Inc. (MO) is a Trending Stock

Here is What to Know Beyond Why Altria Group, Inc. (MO) is a Trending Stock

Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 1 year ago
Altria Lights Up With Strong Growth In Its Smoke-Free Portfolio

Altria Lights Up With Strong Growth In Its Smoke-Free Portfolio

I see Altria benefiting from the shift to smoke-free products as the NJOY and on! brands gain volume while cigarette sales fall. NJOY's device shipments tripled in Q3 2024 with the FDA approving its menthol e-cigarettes, improving its market share to 6.2%. The proliferation of illicit e-vapor products and the ongoing patent fight with Juul pose significant risks to Altria's market share and growth.

Seekingalpha | 1 year ago
Loading...
Load More